Now showing items 1-4 of 4
A1 beta-casein, type 1 diabetes and links to other modern illnesses
(Lincoln University, 2008-04)
The role of milk and milk proteins in relation to human health remains controversial. However, there is a large body of evidence, reviewed in this paper, specifically linking A1 beta-casein to a range of illnesses. A1 ...
The role of the NZFSA in investigating health issues concerning A1 and A2 milk
(Lincoln University. Department of Agricultural Management and Property Studies, 2007-10)
The NZFSA claims (24 Sept 07) that they do not believe ‘A1 milk is any more or less of a riskthan A2 milk’. Presumably they are basing this claim on the report undertaken for them byProfessor Boyd Swinburn in 2004, which ...
Submission to: Review of NZFSA’s risk management framework for making decisions on consumer protection, and with particular reference to issues of A1 and A2 milk
The purpose of this submission is to bring to the attention of Dr Slorach, as the appointed reviewer, various issues associated with the way in which NZFSA has dealt with the issue of A1 and A2 milk.
Comparative effects of A1 versus A2 beta-casein on gastrointestinal measures: A blinded randomised cross-over pilot study
(Macmillan Publishers Limited, 2014-07-02)
At present, there is debate about the gastrointestinal effects of A1-type beta-casein protein in cows' milk compared with the progenitor A2 type. In vitro and animal studies suggest that digestion of A1 but not A2 beta-casein ...